BDBM50056937 3,4-dihydroxy-5-(3,4,5-trihydroxybenzoyloxy)benzoic acid::CHEMBL366356::Gallic acid 3-monogallate::digallic acid

SMILES OC(=O)c1cc(O)c(O)c(OC(=O)c2cc(O)c(O)c(O)c2)c1

InChI Key InChIKey=COVFEVWNJUOYRL-UHFFFAOYSA-N

Data  8 IC50

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 8 hits for monomerid = 50056937   

TargetIntegrase(Human immunodeficiency virus type 1)
National Cancer Institute-Bethesda

Curated by ChEMBL
LigandPNGBDBM50056937(3,4-dihydroxy-5-(3,4,5-trihydroxybenzoyloxy)benzoi...)
Affinity DataIC50: 2.20E+3nMAssay Description:Inhibitory concentration of compound against strand transfer of HIV-1 integraseMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/6/2012
Entry Details Article
PubMed
TargetIntegrase(Human immunodeficiency virus type 1)
National Cancer Institute-Bethesda

Curated by ChEMBL
LigandPNGBDBM50056937(3,4-dihydroxy-5-(3,4,5-trihydroxybenzoyloxy)benzoi...)
Affinity DataIC50: 1.50E+3nMAssay Description:Inhibitory concentration of compound against 3'-processing of HIV-1 integrase in experiment 2More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/6/2012
Entry Details Article
PubMed
TargetIntegrase(Human immunodeficiency virus type 1)
National Cancer Institute-Bethesda

Curated by ChEMBL
LigandPNGBDBM50056937(3,4-dihydroxy-5-(3,4,5-trihydroxybenzoyloxy)benzoi...)
Affinity DataIC50: 900nMAssay Description:Inhibitory concentration of compound against 3'-processing of HIV-1 integrase in experiment 1More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/6/2012
Entry Details Article
PubMed
TargetIntegrase(Human immunodeficiency virus type 1)
National Cancer Institute-Bethesda

Curated by ChEMBL
LigandPNGBDBM50056937(3,4-dihydroxy-5-(3,4,5-trihydroxybenzoyloxy)benzoi...)
Affinity DataIC50: 600nMAssay Description:Inhibitory concentration of compound against strand transfer of HIV-1 integrase in experiment 2More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/6/2012
Entry Details Article
PubMed
TargetIntegrase(Human immunodeficiency virus type 1)
National Cancer Institute-Bethesda

Curated by ChEMBL
LigandPNGBDBM50056937(3,4-dihydroxy-5-(3,4,5-trihydroxybenzoyloxy)benzoi...)
Affinity DataIC50: 600nMAssay Description:Inhibitory activity against HIV-1 integraseMore data for this Ligand-Target Pair
In Depth
Date in BDB:
10/11/2012
Entry Details Article
PubMed
TargetIntegrase(Human immunodeficiency virus type 1)
National Cancer Institute-Bethesda

Curated by ChEMBL
LigandPNGBDBM50056937(3,4-dihydroxy-5-(3,4,5-trihydroxybenzoyloxy)benzoi...)
Affinity DataIC50: 600nMAssay Description:Inhibitory concentration of compound against strand transfer of HIV-1 integrase in experiment 1More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/6/2012
Entry Details Article
PubMed
TargetIntegrase(Human immunodeficiency virus 2)
National Cancer Institute-Bethesda

Curated by ChEMBL
LigandPNGBDBM50056937(3,4-dihydroxy-5-(3,4,5-trihydroxybenzoyloxy)benzoi...)
Affinity DataIC50: 2.50E+3nMAssay Description:Inhibitory concentration of compound against 3'-processing of HIV-2 integraseMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/6/2012
Entry Details Article
PubMed
TargetAnthrax toxin receptor 2(Human)
Harvard Medical School

Curated by ChEMBL
LigandPNGBDBM50056937(3,4-dihydroxy-5-(3,4,5-trihydroxybenzoyloxy)benzoi...)
Affinity DataIC50: 5.00E+4nMAssay Description:Inhibition of CMG2 (40 to 217) C175A and R40C double mutant (unknown origin) interaction to full length PA E733C mutant expressed in Escherichia coli...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/31/2020
Entry Details Article
PubMed